Skip to content
MedsAcross

Medicine

Gadobutrol 1209.44 mg/2 mL injection

Gadobutrol · Intravenous
Available on requestPrescription onlyUS FDAGeneric name

Gadobutrol 1209.44 mg/2 mL injection is a generic prescription medicine for intravenous use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Should freezing occur, gadobutrol injection should be brought to room…

Key facts

Active ingredient (INN)
Gadobutrol
Brand
Sold under the generic name
Strength
1209.44 mg/2 mL
Dosage form
Injection
Route
Intravenous
Packs
5 cartons of 2 mL, 3 vials of 2 mL
Manufacturers
Fresenius KabiSlate Run Pharmaceuticals
Origin register
US FDA, United States
Storage
Should freezing occur, gadobutrol injection should be brought to room temperature before use. Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F). If allowed to stand at room temperature, gadobutrol injection should return to a clear and colorless to pale yellow solution.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
V08CA09 Gadobutrol
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
14 April 2023
Identifiers
DailyMed set ID 832e0ae1-4fe1-4dff-9978-c9200bcebb55, 007696d0-4b62-4937-9640-4ad619504df4NDC 70436-218, 65219-281Application ANDA217480, ANDA215061

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
5 carton in 1 box / 3 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose65219-281-02Fresenius Kabi14 April 2023
3 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose70436-218-84Slate Run Pharmaceuticals16 April 2025

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 14 March 2011Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Gadobutrol 1209.44 mg/2 mL injection.

Compare all 2

Other strengths and forms of Gadobutrol

Clinical summary

Gadobutrol is a gadolinium-based contrast agent indicated for magnetic resonance imaging (MRI) of the central nervous system (CNS) to detect and visualize areas with disrupted blood brain barrier and/or abnormal vascularity in adult, among other approved uses. MedsAcross supplies Gadobutrol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Gadobutrol

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Gadobutrol 1209.44 mg/2 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.